SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001607062-19-000429
Filing Date
2019-11-12
Accepted
2019-11-12 09:30:35
Documents
90
Period of Report
2019-07-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K gnbt073119form10k.htm 10-K 1961102
2 EXHIBIT 31.1 ex31_1.htm EX-31.1 18464
3 EXHIBIT 31.2 ex31_2.htm EX-31.2 18186
4 EXHIBIT 32. ex32.htm EX-32 6856
5 GRAPHIC image_001.jpg GRAPHIC 5829
6 GRAPHIC image_001.gif GRAPHIC 1339
7 GRAPHIC image_002.jpg GRAPHIC 322974
  Complete submission text file 0001607062-19-000429.txt   8280695

Data Files

Seq Description Document Type Size
8 XBRL INSTANCE FILE gnbt-20190731.xml EX-101.INS 1470691
9 XBRL SCHEMA FILE gnbt-20190731.xsd EX-101.SCH 75096
10 XBRL CALCULATION FILE gnbt-20190731_cal.xml EX-101.CAL 62745
11 XBRL DEFINITION FILE gnbt-20190731_def.xml EX-101.DEF 305842
12 XBRL LABEL FILE gnbt-20190731_lab.xml EX-101.LAB 417691
13 XBRL PRESENTATION FILE gnbt-20190731_pre.xml EX-101.PRE 416205
Mailing Address 10102 USA TODAY WAY MIRAMAR FL 33025
Business Address 10102 USA TODAY WAY MIRAMAR FL 33025 416-364-2551
GENEREX BIOTECHNOLOGY CORP (Filer) CIK: 0001059784 (see all company filings)

IRS No.: 820490211 | State of Incorp.: DE | Fiscal Year End: 0731
Type: 10-K | Act: 34 | File No.: 000-25169 | Film No.: 191206634
SIC: 2834 Pharmaceutical Preparations